- Title
- Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1: A Randomized Trial
- Creators
- Eric S DAAR - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesCamlin TIERNEY - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesAwny FARAJALLAH - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesJames F ROONEY - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesKeith A PAPPA - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesWilliam C WOODWARD - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesKristine PATTERSON - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesHector BOLIVAR - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesConstance A BENSON - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesAnn C COLLIER - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesMargaret A FISCHL - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesPaul E SAX - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesKatie MOLLAN - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesChakra BUDHATHOKI - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesCatherine GODFREY - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesNasreen C JAHED - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesLaurie MYERS - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United StatesDavid KATZENSTEIN - Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center and the University of California, Los Angeles, Los Angeles, California, United States
- Publication Details
- Annals of internal medicine, Vol.154(7), pp.445-456
- Publisher
- American College of Physicians; Philadelphia, PA
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Infectious Diseases
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031577429302976
Journal article
Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1: A Randomized Trial
Annals of internal medicine, Vol.154(7), pp.445-456
2011
Metrics
3 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.66 HIV
- 1.66.1372 Lipodystrophy
- Web Of Science research areas
- Medicine, General & Internal
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites